Research Article
Diagnosis of Follicular Variant of Papillary Thyroid Cancer: Is Frozen Section a Guide for the Surgeon?
Hakan Kaya1*, Burak Ertaş2, Neslihan Kurtulmuş3, Ümit İnce4, Serdar Giray1 and Mete Düren1
1Thyroid Clinic of Acıbadem Medical Faculty Hospital, Acıbadem University, Turkey
2Department of Otorhinolaryngology, Acıbadem University, Turkey
3Department of Endocrinology, Division of Internal Medicine, Acıbadem University, Turkey
4Department of Pathology, Acıbadem University, Turkey
*Corresponding author: Hakan Kaya, Department of General Surgery, Acıbadem Maslak Hospital, Büyükdere Cad. No: 40, 34457 Maslak, İstanbul, Turkey
Published: 06 Dec, 2016
Cite this article as: Kaya H, Ertaş B, Kurtulmuş N, İnce
Ü, Giray S, Düren M. Diagnosis of
Follicular Variant of Papillary Thyroid
Cancer: Is Frozen Section a Guide for
the Surgeon?. Clin Surg. 2016; 1: 1210.
Abstract
Introduction: Fine needle aspiration cytology (FNAC) is a useful tool in the diagnosis of papillary thyroid cancer (PTC). However, it is difficult to diagnose the follicular variant of PTC (FVPTC)
preoperatively via FNAC or frozen section (FS) examination. In this retrospective study, we
measured the sensitivities of, and extent of agreement between, these two diagnostic tools in patients
ultimately diagnosed with FVPTC.
Materials and Methods: Between November 2013 and December 2014, a total of 100 patients
were diagnosed with FVPTC and operated upon in the Thyroid Clinic of Acibadem Hospital. All
patients were operated upon by the same surgeon, and all FNAC and FS data were evaluated by
the same cytopathologist and histopathologist, respectively. The sensitivities of FNAC and FS were
determined, and the Kappa test was used to calculate the extent of agreement between the two tools.
Results: A total of 78 patients underwent bilateral total thyroidectomy and 22 completion
thyroidectomy following diagnostic lobectomy. The FNAC results were benign (25%), atypical cells/
follicular lesions of unknown significance (AFCUS) (14%), follicular neoplasia (31%), suspicious
for PTC (18%), and PTC (12%). The FS results were benign (27%), follicular neoplasia (46%),
suspicious for PTC (13%), and PTC (14%). Surgery was scheduled for patients with nodules larger
than 3 cm that were benign on FNAC, those who had nodules of any size and were repeatedly of
FNAC AFCUS status, and those who had nodules of any size and FNAC indications of follicular
neoplasia, suspicion of PTC, or PTC. The sensitivity of FNAC used to diagnose FVPTC was 32.4%
and that of FS 34.1%. Moderate agreement was evident between the two diagnostic tools, with a
Kappa value of 0.423 (95% confidence interval, 0.078-0.747). Patients for whom the FS data raised
a suspicion of PTC or indicated the presence of PTC underwent bilateral total thyroidectomy as the
initial surgery. The initial surgical strategy was changed in 17% of patients after FS analysis indicated
a suspicion of PTC or PTC.
Conclusion: Although the utility of FS data is debatable in patients who undergo surgery for
treatment of thyroid nodules, we found that the FS results may change the initial surgical strategy
and reduce the need for completion thyroidectomy.
Introduction
Thyroid carcinoma is the most common endocrine malignancy, and papillary thyroid
carcinoma (PTC) constitutes up to 90% of cases [1]. The recentrise in disease prevalence is probably
attributed to the increased resolution of ultrasound probes, which now detect smaller lesions,
including microcarcinomas [2] Many PTC variants have been defined; the classical and follicular
variants are the most common [3]. Follicular variant papillary thyroid carcinoma (FVPTC) is a
well-defined histopathological form of PTC accounting for 24-33% of all PTCs. FVPTC exhibits
the nuclear features of classical variant papillary carcinoma (CVPTC) and a follicular growth
pattern. The follicular arrangement of tumor cells can cause CVPTC to be misdiagnosed as other
follicular lesions, including adenomatous nodules, follicular adenoma, and follicular carcinoma [4]
Sonographically, the tumor margins are well defined, the tumor is not round, and microcalcification
is absent. These features are typical of benign tumors, causing malignant lesions to be overlooked [5]
The clinical behavior of FVPTC is intermediate between that of papillary and follicular neoplasia,
but the incidences of lymph node metastasis and extra thyroidal extension are lower, although
distant metastases have been reported. The disease is less aggressive
and associated with outcomes similar to or better than those of
CVPTC. The biological behavior of non-invasive FVPTC resembles
that of follicular adenoma [6].
Ultrasonography (USG)-guided fine needle aspiration cytology
(FNAC) is accepted to be the gold standard for diagnosis of thyroid
nodules, with a sensitivity of 83-98% [7]. The thyroid is the most
frequently biopsied organ; USG-guided FNAC affords excellent
diagnostic accuracy [8]. FNAC candidates include male patients
with thyroid nodules greater than 1 cm in diameter, patients with
family histories of thyroid malignancy, patients who have received
neck external beam therapy, patients with evidence of hard and
fixed nodules on palpation, and patients with non-palpable nodules
but malignant sonographic findings [9]. Because FVPTC does not
adequately exhibit the cytological features of PTC, it is detected less
sensitively by FNAC (25-42%), and false-negatives have been reported.
In addition, the patchy distribution of FVPTC within a nodule may
lead to FNAC false-negativity if the nodule is sampled inaccurately
[10]. A core needle biopsy is not routinely recommended, because the
gland is highly vascular.
The sensitivity of FS analysis in detecting FVPTC ranges from
29to 73% and is believed to be lower than that for the nonfollicular
variant. Some studies have suggested that both FNAC and FS analysis
afford high-level diagnostic sensitivities and specificities; others found
that FS examination was better than was FNAC for distinguishing
between benign and malign thyroid nodules [11].
These difficulties in FVPTC diagnosis pose treatment problems.
The preferred treatment for PTCs larger than 1 cm in diameter is
bilateral total thyroidectomy [12]. If an FVPTC is encapsulated, the
tumor behavior is believed to be similar to that of a follicular neoplasia.
The diffuse form of FVPTC metastasizes to regional lymph nodes,
as does CVPTC. This may explain the lower incidence of lymph no
demetastasis and the relatively higher incidences of lung and bone
metastases of FVPTC compared with CVPTC [13]. Misdiagnosis of
FVPTC as a benign follicular lesion will mostly likely lead to plans
for a lobectomy, which will in turn trigger the need for completion
thyroidectomy, increasing patient morbidity and cost [14].
The aim of the present study was to assess the efficacy of FNAC
and FS analysis in the diagnosis of FVPTC.
Material and Methods
This retrospective study was approved by the institutional review
board of Acibadem Maslak Hospital. We retrospectively reviewed
100 consecutive cases of cytologically confirmed FVPTC who
underwent operations between November 2013 and December 2014.
FNAC of all suspect nodules was performed under USG guidance.
On-site cytopathological examinations were performed to ensure
appropriate lesion sampling. All patients were operated upon by the
same surgeon, and all FNAC and FS specimens were examined by the
same cytopathologist and histopathologist, respectively.
Statistical analysis
The sensitivities of FNAC and FS were determined, and the
Kappa test was used to determine the extent of agreement between
the two tools.
Table 1
Table 2
Results
A total of 78 female and 22 male patients were included. The
median patient age was 42 years (range, 18-78years). The median age
of the female patients was 40.5 years and that of the male patients50
years. A total of 78 patients underwent bilateral total thyroidectomy
and 22 completion thyroidectomy following diagnostic lobectomy.
The mean tumor diameter was 15.03 mm. The tumors were located in
the right lobe in 39 patients, the left lobe in 37, and bilateral tumors
were seen in 23. One tumor was located in the isthmus. The tumors of
37 patients were multicentric. Sixty-five patients underwent FNAC;
the results (using the Bethesda classification (Table 1) were as follows:
16 patients of class 2 (25%), 9 of class 3(14%), 20 of class 4 (31%),
12 of class 5 (18%), and 8of class 6 (12%). FS examination showed
that 27 patients had benign nodules, and14 had malignant nodules.
Thirteen patients were found to be suspicious for malignancy, and
46nodules were reported to be follicular neoplasias (Table 2). Tumor
capsules were evident in 52 specimens, and 23 exhibited tumor
capsule invasion.
Surgery was performed on patients with nodules larger than 3 cm
that were benign on FNAC, patients who had nodules of any size and
were repeatedly of FNAC AFCUS status, and patients who had nodules
of any size and FNAC indications of follicular neoplasia, suspicion
of PTC, or PTC. The sensitivity of FNAC for FVPTC detection was
32.4% and that of FS analysis 34.1%. Moderate agreement was evident
between the two tools, with a Kappa value of 0.423 (95% CI 0.078-
0.747). Patients for whom the FS data raised a suspicion of PTC or
identified PTC underwent bilateral total thyroidectomy as the initial
surgery. The initial surgical strategy was changed in 17% of patients
for whom FS examination raised a suspicion of PTC or identified
PTC. We performed completion thyroidectomy in all T2 patients,
because we routinely recommend radioactive iodine ablation to all
such patients.
No patient underwent central neck dissection, but
three had metastatic lymph nodes. Fifteen patients required
immunohistochemical evaluation of their tumor tissues to yield the
final pathological diagnoses. After surgery, radioactive iodine was
given to 38 patients. Only one patient suffered bone metastasis.
Discussion
The prognosis of PTC is favorable [15]. Although diffuse FVPTC
can trigger distant metastases, non-invasive FVPTC has a very low
metastatic potential and recurrence rate; the 10-year survival rate
is>90% [16]. Treatment is based on the histopathological findings.
FNAC and FS examination are both routinely used to manage
thyroid nodules [17]. PTC should be diagnosed either preoperatively
or perioperatively. A lobectomy (only) may be necessary if the
nodule is benign, whereas PTC may require bilateral lobectomy. A
misdiagnosis may lead to completion thyroidectomy, increasing the
cost and patient morbidity [14].
The sensitivity of FNAC is high when used to detect PTC,
but diagnosis of the follicular variant may pose difficulties to the
cytopathologist. The nuclear features are not as prominent as those of
CVPTC, and the tumor has a patchy distribution within the nodule,
which causes inappropriately obtained samples to yield false-negative
findings. FVPTC can be confused with other follicular lesions
including follicular adenoma [18]. A core biopsy is not routinely
recommended, because the gland is highly vascular.
FS analysis may aid in determining the correct diagnosis of
misdiagnosed FVPTC during surgery. Although the use of FS data
remains controversial, the technique may be of preoperative utility
in patients for whom the FNAC findings raise suspicions. In our
present study, 3 of 29 patients (10%) who had nodules preoperatively
diagnosed as follicular lesions/AFCUS/follicular neoplasms were
found to be suspicious for PTC intraoperatively. Two of these 29
patients (7%) were diagnosed with PTC upon examination of the
FS data. In addition, FS analysis resulted in changing the diagnosis
from PTC to a follicular lesion in 5 of 20 patients (25%) who had
preoperative FNAC diagnoses of suspicious for PTC or definite PTC.
The sensitivities of FNAC and FS analysis for the diagnosis of FVPTC
were 32.4% and 34.1%, respectively. FS data caused us to change our
operative technique to bilateral total thyroidectomy in 17% of all
patients, thus eliminating the need for later completion surgery. FS
evaluation seems to be logical when the risk of complications, costs,
and stress associated with completion thyroidectomy are considered.
We recommend that FS examinations be continued until more
sensitive molecular techniques supplant FNAC.
References
- Kurian EM, Dawlett M, Wang J, Gong Y, Guo M. The Triage Efficacy of Fine Needle Aspiration Biopsy for Follicular Variant of Papillary Thyroid Carcinoma Using the Bethesda Reporting Guidelines. Diagn Cytopathol. 2011; 40: 69-73.
- Faquin WC, Wong LQ, Afrogheh AH, Ali SZ, Bishop JA, Bongiovanni M, et al. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol. 2016; 124: 181-187.
- Yu X-M, Schneider DF, Leverson G, Chen H, Sippel RS. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a populationbased study of 10,740 cases. Thyroid. 2013; 23: 1263-1268.
- D M, T M K, Khan DM, Raman RT. Follicular variant of papillary thyroid carcinoma: cytological indicators of diagnostic value. J Clin Diagn Res. 2014; 8: 46–48.
- Kim DS, Kim JH, Na DG, Park SH, Kim E, Chang KH, et al. Sonographic features of follicular variant papillary thyroid carcinomas in comparison with conventional papillary thyroid carcinomas. J Ultrasound Med. 2009; 28: 1685-1692.
- Singhal S, Sippel RS, Chen H, Schneider DF. Distinguishing classical papillary thyroid microcancers from follicular-variant microcancers. J Surg Res. 2014; 190: 151–156.
- Yoon JH, Kwon HJ, Kim E-K, Moon HJ, Kwak JY. The follicular variant of papillary thyroid carcinoma: characteristics of preoperative ultrasonography and cytology. Ultrasonography. 2016; 35: 47-54.
- Chaves S, Fernández-Aceñero MJ, Cazorla a, Cedeño M, Fortes J, Gavín E, et al. Implementation of a joint protocol for the management of thyroid nodules with a cytological diagnosis of follicular lesion of undetermined significance: experience in one hospital. Cytopathology. Cytopathology. 2013; 24: 81-84.
- Teixeira GV, Chikota H, Teixeira T, Manfro G, Pai SI, Tufano RP. Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration. World J Surg. 2012; 36: 69-74.
- Lin HS, Komisar A, Opher E, Blaugrund SM. Follicular variant of papillary carcinoma: the diagnostic limitations of preoperative fine-needle aspiration and intraoperative frozen section evaluation. Laryngoscope. 2000; 110: 1431–1436.
- Pusztaszeri M. Follicular variant of papillary thyroid carcinoma: distinct biologic behavior based on ultrasonographic features. Thyroid. 2014; 24: 1067–1068.
- Blanchard C, Brient C, Volteau C, Sebag F, Roy M, Drui D, et al. Factors predictive of lymph node metastasis in the follicular variant of papillary thyroid carcinoma. Br J Surg. 2013; 100: 1312–1317.
- Rhee SJ, Hahn SY, Ko ES, Ryu JW, Ko EY, Shin JH. Follicular variant of papillary thyroid carcinoma: distinct biologic behavior based on ultrasonographic features. Thyroid. 2014; 24: 683–688.
- Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006; 107: 1255–1264.
- Chai YJ, Suh H, Yi JW, Yu HW, Lee J-H, Kim SJ, et al. Factors associated with the sensitivity of fine-needle aspiration cytology for the diagnosis of follicular variant papillary thyroid carcinoma. Head Neck. 2016. 38: 1467- 71.
- Tunca F, Sormaz IC, Iscan Y, Senyurek YG, Terzioglu T. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma. J Endocrinol Invest. Italy 2015; 38: 1327- 1334.
- Kesmodel SB, Terhune KP, Canter RJ, Mandel SJ, LiVolsi VA, Baloch ZW, et al. The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery. 2003; 134: 1005-1012.
- Kragel C Shattuck TM. The Follicular Variant of Papillary Thyroid Carcinoma as a Source of False Negative Cytopathology : A Report of Four Cases with an Emphasis on the Multifocality of Nuclear Changes. Diagn Cytopathol. 2014; 43: 1-4.